Chief Investment Officer
Anders is an experienced investment and business development professional with broad experience from the life science industry covering management positions, strategy and business development, research collaborations, licensing deals, M&A and IPOs.
Einarsson has for the last 20 years acted as the CEO for RADFORSK. During this time, he has transferred RADFORSK from being a Technology Tech Transfer Office for the Norwegian Radium Hospital, to one of the most successful preseed investors in Europe with focus on startup companies based on Norwegian research within immunoncology.
Einarsson is also the founder and former CEO and Chairman of the board, of Oslo Cancer Cluster and the Oslo Cancer Cluster Innovation Park. He is today acting as senior adviser for Oslo Cancer Cluster and as a member of the board of the Innovation Park.
Before joining RADFORSK, Einarsson was the CEO and Chairman of the board of Norway’s first private hospital, Oslo Private Sykehus AS, and he acted as GP and Chief Medical Officer of Lærdal Municipality for ten years.